M A Lebedeva Selected Research

M A Lebedeva Research Topics

5	Myocardial Infarction 08/2020 - 01/2011
4	Hypoxia (Hypoxemia) 04/2013 - 01/2006
2	Transient Ischemic Attack 01/2014 - 01/2012
1	Hearing Loss (Hearing Impairment) 01/2021
1	Tinnitus 01/2021
1	Cicatrix (Scar) 08/2020
1	Fibrosis (Cirrhosis) 08/2020
1	Necrosis 08/2020
1	Neoplasms (Cancer) 01/2015
1	Hypokinesia (Bradykinesia) 01/2014
1	Brain Ischemia (Cerebral Ischemia) 01/2011
1	Ischemia 01/2011
1	Hypercapnia 10/2010
1	Pain (Aches) 07/2008
1	Trigeminal Neuralgia (Tic Douloureux) 07/2008
1	Hypocapnia 02/2008

3	gamma-Aminobutyric Acid (GABA)IBA 01/2014 - 01/2006
2	emoxypine succinateIBA 01/2014 - 01/2011
2	PicrotoxinIBA 04/2013 - 02/2008
2	Aminophylline (Carine)FDA LinkGeneric 10/2010 - 02/2008
1	SuspensionsIBA 08/2020
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 08/2020
1	methionylmethylsulfonium chloride (MMSC)IBA 08/2020
1	Transcription Factors (Transcription Factor)IBA 01/2015
1	Hormones (Hormone)IBA 01/2015
1	LipidsIBA 01/2014
1	MelatoninIBA 01/2014
1	2- ((2- morpholino)ethylthio)- 5- ethoxybenzimidazoleIBA 01/2014
1	Nimodipine (Modus)FDA LinkGeneric 01/2014
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2014
1	Arachidonic Acid (Vitamin F)IBA 01/2014
1	Dopamine (Intropin)FDA LinkGeneric 01/2014
1	Proteins (Proteins, Gene)FDA Link 10/2013
1	3,16-dihydroxyandrost-5-ene-17,19-dioneIBA 01/2012
1	GABA-B ReceptorsIBA 10/2010
1	GABA-A Receptor AntagonistsIBA 02/2008
1	Purinergic P1 Receptor AntagonistsIBA 02/2008
1	lithium hydroxybutyrate (lithium oxybutyrate)IBA 01/2006

1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2021
1	Psychology Biofeedback (Biofeedback) 01/2021
1	Therapeutics 01/2021
1	Lasers (Laser) 10/2013
1	Intravenous Administration 04/2013
1	Decompression 07/2008
1	Aftercare (After-Treatment) 02/2008
1	Intravenous Infusions 01/2006